Bioventus Inc. (BVS)
10.13
-0.01 (-0.10%)
At close: Mar 03, 2025, 3:59 PM
9.65
-4.79%
After-hours: Mar 03, 2025, 07:22 PM EST
Bioventus Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY99 |
| Revenue | 512.35M | 512.12M | 430.9M | 321.16M | 340.14M | 319.18M | 292.06M | 274.5M | 253.65M | 242.89M | 232.38M | 64.77M |
| Cost of Revenue | 184.15M | 181.04M | 128.19M | 87.64M | 90.94M | 84.17M | 92.1M | 91.39M | 74.34M | 74.61M | 71.37M | 18.97M |
| Gross Profit | 328.19M | 331.08M | 302.71M | 233.52M | 249.21M | 235.01M | 199.96M | 183.11M | 179.31M | 168.28M | 161M | 45.81M |
| Operating Income | -81.72M | -35.68M | 17.72M | 21.24M | 31.19M | 25.5M | 27.02M | 14.89M | -16.59M | 20K | -8.07M | -35.67M |
| Interest Income | n/a | 25.8M | 1.11M | 9.75M | 21.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -121.11M | -263.9M | 7.62M | 15.91M | 9.69M | 6.11M | 8.66M | -5.65M | -31.97M | -11.35M | -20.24M | -39.09M |
| Net Income | -156.23M | -213.39M | 9.59M | 16.41M | 6.85M | -12.21M | -1.64M | -17.95M | -34.11M | -12.9M | -22.37M | -39.22M |
| Selling & General & Admin | 303.88M | 332.61M | 254.25M | 193.08M | 198.47M | 191.67M | 164.84M | 160.32M | 148.44M | 147.06M | 150.37M | 76.82M |
| Research & Development | 13.45M | 25.94M | 19.04M | 11.2M | 11.05M | 8.1M | 8.1M | 7.9M | 14.75M | 9.46M | 10.94M | 4.67M |
| Other Expenses | 92.59M | 21.15M | 8.36M | 7.44M | 7.91M | -226K | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 409.92M | 379.7M | 281.65M | 211.72M | 217.44M | 207.64M | 172.94M | 168.22M | 173.76M | 165.49M | 169.07M | 81.48M |
| Interest Expense | 40.68M | 25.8M | 1.11M | 9.75M | 21.58M | 19.17M | 18.9M | 15.94M | 14.23M | 11.97M | 11.46M | 3.64M |
| Selling & Marketing Expenses | 3.85M | 5.2M | 3.87M | 2.77M | 2.35M | n/a | n/a | n/a | n/a | n/a | n/a | 42.9M |
| Cost & Expenses | 594.07M | 560.74M | 409.85M | 299.36M | 308.37M | 291.81M | 265.04M | 259.61M | 248.1M | 240.1M | 240.44M | 100.45M |
| Income Tax | 85K | -50.51M | -1.97M | 1.19M | 1.58M | 1.66M | -785K | 1.09M | 2.14M | 1.55M | 2.13M | 132K |
| Shares Outstanding (Basic) | 62.65M | 61.39M | 59.55M | 56.83M | 56.83M | 55.63M | 56.83M | 56.83M | 55.63M | 55.63M | 55.63M | n/a |
| Shares Outstanding (Diluted) | 62.65M | 61.39M | 59.55M | 56.83M | 56.83M | 55.63M | 56.83M | 56.83M | 55.63M | 55.63M | 55.63M | n/a |
| EPS (Basic) | -2.49 | -3.48 | 0.16 | 0.08 | -0.01 | -0.22 | -0.03 | -0.32 | -0.61 | -0.23 | -0.4 | n/a |
| EPS (Diluted) | -2.49 | -3.48 | 0.16 | 0.08 | -0.01 | -0.22 | -0.03 | -0.32 | -0.61 | -0.23 | -0.4 | n/a |
| EBITDA | -23.07M | -109.2M | 51.81M | 50.44M | 61.58M | 54.52M | 59.32M | 48.65M | 15.18M | 34.42M | 15.68M | -16.48M |
| Depreciation & Amortization | 57.37M | 61.4M | 38.68M | 28.64M | 30.32M | 29.24M | 32.29M | 33.76M | 33.08M | 28.82M | 24.46M | 18.97M |